ArticleAddictive behaviors reports2026
Awareness, use and future interest in cytisine for smoking cessation in adults who smoke or have quit within the past year in the UK: A mixed-methods study.
Article in Addictive behaviors reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Cytisine is an effective smoking cessation pharmacotherapy introduced in the UK in 2024. Assessing awareness, use, and interest is essential to assess its potential role in smoking cessation. We examined cytisine awareness and use among people who smoked in the past year, and interest in and factors influencing future use among people who currently smoke. Methods: An explanatory sequential mixed-method design study conducted between April-July 2025 in the UK; 193 people reporting past-year smoking (mean-age = 37.7,SD = 13.4) completed an online survey, and 16 participated in semi-structured interviews. Logistic regression examined correlates of cytisine awareness and interest in future use. Interviews were analysed thematically using the COM-B framework to explore perceived barriers and facilitators to cytisine use. Results: Cytisine awareness was low ( Conclusions: Despite low awareness and use of cytisine, interest in future use is high. Addressing informational and practical barriers could support wider cytisine uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.